🇺🇸 FDA
Patent

US 7579006

Method of treating immune pathologies with low dose estrogen

granted A61KA61K31/56A61K31/565

Quick answer

US patent 7579006 (Method of treating immune pathologies with low dose estrogen) held by THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIR expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIR
Grant date
Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/56, A61K31/565, A61K31/566, A61K38/191